The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Patel Prashant | Chief Executive Officer, Director | Option exercise(X) | 100K | — | $0 |
| Jun 22, 2026 | Patel Prashant | Chief Executive Officer, Director | Option exercise(X) | 100K | $0.01 | $500 |
| Jun 22, 2026 | Ajjarapu Surendra K | Director | Option exercise(X) | 100K | — | $0 |
| Jun 22, 2026 | Ajjarapu Surendra K | Director | Option exercise(X) | 100K | $0.01 | $500 |
| Mar 31, 2026 | Patel Prashant | Chief Executive Officer, Director | Grant(A) | 5.0M | $0.01 | $50K |
| Mar 31, 2026 | Patel Prashant | Chief Executive Officer, Director | Grant(A) | 5.0M | $0.20 | $1.0M |
| Mar 31, 2026 | Ajjarapu Surendra K | Director | Grant(A) | 5.0M | $0.01 | $50K |
| Mar 31, 2026 | Ajjarapu Surendra K | Director | Grant(A) | 5.0M | $0.20 | $1.0M |
| Mar 31, 2026 | Ajjarapu Surendra K | Director | Grant(A) | 5.0M | $0.00 | $500 |
| Mar 31, 2026 | Ajjarapu Surendra K | Director | Grant(A) | 5.0M | $0.20 | $1.0M |
| Mar 31, 2026 | Patel Prashant | Chief Executive Officer, Director | Grant(A) | 5.0M | $0.00 | $500 |
| Mar 31, 2026 | Patel Prashant | Chief Executive Officer, Director | Grant(A) | 5.0M | $0.20 | $1.0M |
| Jul 2, 2025 | Peterson Michael L | Director | Grant(A) | 200K | $0.90 | $180K |
| Mar 21, 2025 | Shanahan Rebecca M | Director | Grant(A) | 200K | — | $0 |
| Mar 21, 2025 | Panchal Nikul | Chief Pharmacy Officer | Grant(A) | 90K | — | $0 |
| Mar 21, 2025 | Norton Brian | Chief Executive Officer | Grant(A) | 9.0M | — | $0 |
| Mar 21, 2025 | Anderson Donald William | Director | Grant(A) | 200K | — | $0 |
| Mar 21, 2025 | Patel Prashant | Chief Strategy Officer, Director | Grant(A) | 700K | — | $0 |
| Mar 21, 2025 | Patel Prashant | Chief Strategy Officer, Director | Grant(A) | 1.5M | — | $0 |
| Mar 21, 2025 | Patel Prashant | Chief Strategy Officer, Director | Grant(A) | 1.9M | — | $0 |
| Mar 21, 2025 | Ajjarapu Surendra K | Director | Grant(A) | 2.9M | — | $0 |
| Mar 21, 2025 | Ajjarapu Surendra K | Director | Grant(A) | 600K | — | $0 |
| Mar 21, 2025 | Ajjarapu Surendra K | Director | Grant(A) | 600K | — | $0 |
| Mar 21, 2025 | Syed Sajid | Director | Grant(A) | 200K | — | $0 |
| Mar 21, 2025 | Pirani Shafaat | Chief Clinical Officer | Grant(A) | 35K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).